| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
HOOKIPA Pharma (NASDAQ:HOOK) reported its Q4 earnings results on Friday, March 22, 2024 at 07:01 AM.
Here's what investors need to know about the announcement.
HOOKIPA Pharma missed estimated earnings by -16.0%, reporting an EPS of $-0.22 versus an estimate of $-0.19.
Revenue was down $421 thousand from the same period last year.
Last quarter the company beat on EPS by $0.04 which was followed by a 1.0% increase in the share price the next day.
Here's a look at HOOKIPA Pharma's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.21 | -0.21 | -0.23 | -0.21 |
| EPS Actual | -0.17 | -0.22 | -0.27 | -0.17 |
| Revenue Estimate | 4.25M | 4.87M | 4.39M | 7.07M |
| Revenue Actual | 6.87M | 2.68M | 3.18M | 7.83M |
To track all earnings releases for HOOKIPA Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: HOOK
